ATYR PHARMA INC (LIFE)
US0021202025 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -53.94M | -50.40M | -45.34M | -33.78M | -16.23M | |||
| Depreciation Amortization | 690.00K | 592.00K | 230.00K | 480.00K | 570.00K | |||
| Change In Working Capital | -2.99M | 15.01M | -830.00K | -2.59M | -2.26M | |||
| Interest Paid | 160.00K | 172.00K | 50.00K | 0.00 | 310.00K | |||
| Other non cash items | 1.21M | 1.57M | 4.06M | 2.82M | 2.62M | |||
| OPERATING CASH FLOW | -55.01M | -33.22M | -41.89M | -33.08M | -15.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.98M | -4.21M | -1.64M | -190.00K | -200.00K | |||
| Other Investing Activity | 19.68M | -15.91M | 48.89M | -91.37M | 7.10M | |||
| INVESTING CASH FLOW | 16.69M | -20.13M | 47.25M | -91.57M | 6.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -445.00K | -394.00K | -70.00K | 0.00 | -9.08M | |||
| Stock Issued/Repurchased | 24.91M | 66.62M | 5.52M | 110.03M | 25.23M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 24.46M | 66.23M | 5.45M | 110.03M | 16.14M | |||
| CHANGE IN CASH | -13.86M | 12.88M | 10.81M | -14.62M | 7.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -55.01M | -33.22M | -41.89M | -33.08M | -15.30M | |||
| Capital Expenditure | -2.98M | -4.21M | -1.64M | -190.00K | -200.00K | |||
| FREE CASH FLOW | -57.99M | -37.44M | -43.53M | -33.27M | -15.50M | |||
All data in USD